In a transgenic mouse model of AD, TREM2 deletion exacerbated neuroinflammation via Toll-like receptor 4 (TLR4)-mediated mitogen-activated protein kinase (MAPK) signaling pathway [17]. This evidence concerns the gene TLR4 and Alzheimer disease.